tiprankstipranks
Trending News
More News >
Noile-Immune Biotech Inc. (JP:4893)
:4893
Japanese Market

Noile-Immune Biotech Inc. (4893) Ratios

Compare
0 Followers

Noile-Immune Biotech Inc. Ratios

JP:4893's free cash flow for Q2 2025 was ¥1.00. For the 2025 fiscal year, JP:4893's free cash flow was decreased by ¥ and operating cash flow was ¥-85.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
53.54 53.54 68.77 66.28 13.68
Quick Ratio
53.51 53.51 68.65 66.04 13.67
Cash Ratio
52.66 52.66 67.25 64.41 13.49
Solvency Ratio
-4.78 -9.96 -12.92 -12.35 -1.14
Operating Cash Flow Ratio
0.00 -10.11 -12.79 -10.12 -0.32
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 3.90B¥ 3.90B¥ 4.70B¥ 5.63B¥ 4.24B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.02 1.02 1.02 1.02 1.08
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
6.32 4.91 4.37 7.17 42.51
Profitability Margins
Gross Profit Margin
85.28%100.00%97.43%99.29%98.87%
EBIT Margin
-16284.62%-15945.08%-14092.29%-244.74%-16.99%
EBITDA Margin
-12763.93%-15945.08%-14092.29%-244.74%-16.99%
Operating Profit Margin
-16415.34%-15945.08%-14092.30%-244.74%-16.99%
Pretax Profit Margin
-16269.43%-15822.32%-12680.04%-355.91%-61.40%
Net Profit Margin
-16327.38%-15870.72%-12711.94%-356.68%-61.78%
Continuous Operations Profit Margin
-16327.38%-15870.72%-12711.94%-356.68%-61.78%
Net Income Per EBT
100.36%100.31%100.25%100.21%100.63%
EBT Per EBIT
99.11%99.23%89.98%145.42%361.28%
Return on Assets (ROA)
-19.77%-19.78%-20.09%-19.55%-8.33%
Return on Equity (ROE)
-18.82%-20.18%-20.41%-19.87%-8.99%
Return on Capital Employed (ROCE)
-20.25%-20.25%-22.60%-13.62%-2.47%
Return on Invested Capital (ROIC)
-20.25%-20.25%-22.60%-13.62%-2.47%
Return on Tangible Assets
-19.77%-19.78%-20.09%-19.55%-8.33%
Earnings Yield
-12.05%-13.78%-13.10%-12.85%-1.38%
Efficiency Ratios
Receivables Turnover
0.19 0.19 0.12 4.73 0.00
Payables Turnover
0.00 0.00 0.02 0.12 0.03
Inventory Turnover
0.00 0.00 0.02 0.11 1.80
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
<0.01 <0.01 <0.01 0.05 0.13
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 0.06 0.15
Cash Conversion Cycle
1.97K 1.91K 2.09K 430.70 -11.03K
Days of Sales Outstanding
1.97K 1.91K 3.00K 77.18 0.00
Days of Inventory Outstanding
0.00 0.00 14.97K 3.38K 202.49
Days of Payables Outstanding
0.00 0.00 15.89K 3.03K 11.23K
Operating Cycle
1.97K 1.91K 17.98K 3.46K 202.49
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -17.37 -20.50 -21.05 -2.74
Free Cash Flow Per Share
0.00 0.00 -20.50 -21.05 -2.74
CapEx Per Share
0.00 17.37 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
0.00 0.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -1.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 -1.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.00 -150.44 -117.02 -2.76 -0.17
Free Cash Flow Yield
0.00%0.00%-12.06%-9.93%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.30 -7.26 -7.63 -7.78 -72.44
Price-to-Sales (P/S) Ratio
1.36K 1.15K 970.16 27.75 44.75
Price-to-Book (P/B) Ratio
1.67 1.46 1.56 1.55 6.51
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 0.00 -8.29 -10.07 -261.30
Price-to-Operating Cash Flow Ratio
0.00 -7.66 -8.29 -10.07 -261.30
Price-to-Earnings Growth (PEG) Ratio
5.77 0.41 0.42 -0.04 1.48
Price-to-Fair Value
1.67 1.46 1.56 1.55 6.51
Enterprise Value Multiple
-4.30 -2.31 -2.52 -4.17 -220.83
Enterprise Value
2.66B 1.84B 2.69B 3.24B 23.48B
EV to EBITDA
-4.30 -2.31 -2.52 -4.17 -220.83
EV to Sales
548.39 368.16 354.63 10.21 37.53
EV to Free Cash Flow
0.00 0.00 -3.03 -3.71 -219.12
EV to Operating Cash Flow
0.00 -2.45 -3.03 -3.71 -219.12
Tangible Book Value Per Share
90.80 90.80 109.14 137.15 109.80
Shareholders’ Equity Per Share
90.80 90.80 109.14 137.15 109.80
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
0.11 0.12 0.18 7.64 15.98
Net Income Per Share
-18.31 -18.33 -22.28 -27.25 -9.87
Tax Burden
1.00 1.00 1.00 1.00 1.01
Interest Burden
1.00 0.99 0.90 1.45 3.61
Research & Development to Revenue
74.18 72.18 76.43 2.04 0.54
SG&A to Revenue
0.00 0.00 65.47 1.40 0.62
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.95 0.92 0.77 0.28
Currency in JPY